NLRC4 and macrophage activation syndrome: Patients with NLRC4 Thr337Ser mutations exhibit a substantial increase in plasma IL-18 to levels comparable to other instances of MAS flares in SJIA, AOSD, and infection, which is not present in non-MAS inflammasomopathies such as NOMID [67, 68].